(Reuters) – The U.S. Food and Drug Administration and Johnson & Johnson are expected to announce as early as Friday that contamination problems at a COVID-19 vaccine plant in Baltimore are resolved, the Wall Street Journal reported on Thursday.
(Reporting by Sahil Shaw in Bengaluru; Editing by Chris Reese)
